FDA
approval
· 2023-12-15
FDA Approved: ZORYVE — Original Application (Arcutis Biotherapeutics, Inc.)
Summary
FDA approved ZORYVE (roflumilast) topical cream as an original application for treating plaque psoriasis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ZORYVE (ROFLUMILAST)